Correlation Between GRUPO CARSO and Syndax Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GRUPO CARSO and Syndax Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GRUPO CARSO and Syndax Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GRUPO CARSO A1 and Syndax Pharmaceuticals, you can compare the effects of market volatilities on GRUPO CARSO and Syndax Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GRUPO CARSO with a short position of Syndax Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of GRUPO CARSO and Syndax Pharmaceuticals.

Diversification Opportunities for GRUPO CARSO and Syndax Pharmaceuticals

-0.02
  Correlation Coefficient

Good diversification

The 3 months correlation between GRUPO and Syndax is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding GRUPO CARSO A1 and Syndax Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Syndax Pharmaceuticals and GRUPO CARSO is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GRUPO CARSO A1 are associated (or correlated) with Syndax Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Syndax Pharmaceuticals has no effect on the direction of GRUPO CARSO i.e., GRUPO CARSO and Syndax Pharmaceuticals go up and down completely randomly.

Pair Corralation between GRUPO CARSO and Syndax Pharmaceuticals

Assuming the 90 days trading horizon GRUPO CARSO A1 is expected to generate 1.29 times more return on investment than Syndax Pharmaceuticals. However, GRUPO CARSO is 1.29 times more volatile than Syndax Pharmaceuticals. It trades about 0.01 of its potential returns per unit of risk. Syndax Pharmaceuticals is currently generating about -0.22 per unit of risk. If you would invest  545.00  in GRUPO CARSO A1 on September 23, 2024 and sell it today you would lose (5.00) from holding GRUPO CARSO A1 or give up 0.92% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

GRUPO CARSO A1  vs.  Syndax Pharmaceuticals

 Performance 
       Timeline  
GRUPO CARSO A1 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in GRUPO CARSO A1 are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, GRUPO CARSO is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.
Syndax Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Syndax Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

GRUPO CARSO and Syndax Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GRUPO CARSO and Syndax Pharmaceuticals

The main advantage of trading using opposite GRUPO CARSO and Syndax Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GRUPO CARSO position performs unexpectedly, Syndax Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Syndax Pharmaceuticals will offset losses from the drop in Syndax Pharmaceuticals' long position.
The idea behind GRUPO CARSO A1 and Syndax Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Complementary Tools

Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets